1. Alexander, S. P. H., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Sharman, J. L., Southan, C., Davies, J. A., & Collaborators, C. (2019). The concise guide to pharmacology 2019/20: Transporters. British Journal of Pharmacology, 176(S1), S397–S493.
2. Almasieh, M., Wilson, A. M., Morquette, B., Cueva Vargas, J. L., & Di Polo, A. (2012). The molecular basis of retinal ganglion cell death in glaucoma. Progress in Retinal and Eye Research, 31(2), 152–181.
3. Baltmr, A., Duggan, J., Nizari, S., Salt, T. E., & Cordeiro, M. F. (2010). Neuroprotection in glaucoma – Is there a future role? Experimental Eye Research, 91(5), 554–566.
4. Beart, P. M., & O’Shea, R. D. (2007). Transporters for L-glutamate: An update on their molecular pharmacology and pathological involvement. British Journal of Pharmacology, 150(1), 5–17.
5. Beraudi, A., Bruno, V., Battaglia, G., Biagioni, F., Rampello, L., Nicoletti, F., & Poli, A. (2007). Pharmacological activation of mGlu2/3 metabotropic glutamate receptors protects retinal neurons against anoxic damage in the goldfish Carassius auratus. Experimental Eye Research, 84(3), 544–552.